Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Abdomen | 3 | 2021 | 135 | 1.470 |
Why?
|
| Hernia, Ventral | 5 | 2025 | 38 | 0.950 |
Why?
|
| Surgeons | 4 | 2022 | 286 | 0.840 |
Why?
|
| Return to Work | 1 | 2021 | 12 | 0.710 |
Why?
|
| Herniorrhaphy | 5 | 2025 | 78 | 0.640 |
Why?
|
| Recovery of Function | 1 | 2021 | 462 | 0.600 |
Why?
|
| Activities of Daily Living | 1 | 2021 | 428 | 0.590 |
Why?
|
| Sexism | 5 | 2024 | 43 | 0.570 |
Why?
|
| Robotic Surgical Procedures | 4 | 2023 | 223 | 0.530 |
Why?
|
| Physicians, Women | 3 | 2020 | 52 | 0.450 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 768 | 0.430 |
Why?
|
| Laparoscopy | 4 | 2023 | 523 | 0.400 |
Why?
|
| Thrombelastography | 3 | 2021 | 63 | 0.370 |
Why?
|
| Postoperative Complications | 3 | 2021 | 3142 | 0.320 |
Why?
|
| Authorship | 2 | 2019 | 29 | 0.310 |
Why?
|
| Thrombosis | 3 | 2022 | 524 | 0.290 |
Why?
|
| Critical Illness | 5 | 2022 | 618 | 0.250 |
Why?
|
| Leadership | 4 | 2020 | 246 | 0.230 |
Why?
|
| Biomedical Research | 2 | 2021 | 555 | 0.230 |
Why?
|
| Hernia, Abdominal | 1 | 2024 | 18 | 0.220 |
Why?
|
| Hemostatics | 1 | 2022 | 62 | 0.190 |
Why?
|
| Societies, Medical | 2 | 2024 | 779 | 0.180 |
Why?
|
| Robotics | 1 | 2023 | 108 | 0.180 |
Why?
|
| Periodicals as Topic | 1 | 2024 | 186 | 0.180 |
Why?
|
| Thromboembolism | 1 | 2022 | 93 | 0.170 |
Why?
|
| Pelvis | 1 | 2021 | 74 | 0.170 |
Why?
|
| Postoperative Period | 1 | 2021 | 334 | 0.160 |
Why?
|
| Thrombophilia | 1 | 2020 | 41 | 0.160 |
Why?
|
| Consensus | 4 | 2025 | 651 | 0.150 |
Why?
|
| Peer Review, Research | 1 | 2019 | 44 | 0.150 |
Why?
|
| Anti-Infective Agents | 1 | 2022 | 270 | 0.150 |
Why?
|
| Postoperative Care | 1 | 2021 | 312 | 0.150 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2020 | 197 | 0.150 |
Why?
|
| Gender Identity | 1 | 2019 | 74 | 0.140 |
Why?
|
| Humans | 24 | 2025 | 132089 | 0.140 |
Why?
|
| Fasciitis, Necrotizing | 1 | 2018 | 30 | 0.140 |
Why?
|
| Debridement | 1 | 2018 | 92 | 0.140 |
Why?
|
| Wound Healing | 1 | 2021 | 476 | 0.130 |
Why?
|
| Evidence-Based Medicine | 1 | 2021 | 663 | 0.130 |
Why?
|
| Sepsis | 1 | 2022 | 515 | 0.130 |
Why?
|
| General Surgery | 1 | 2020 | 227 | 0.130 |
Why?
|
| Soft Tissue Infections | 1 | 2018 | 91 | 0.130 |
Why?
|
| Fibrinolysis | 3 | 2022 | 44 | 0.130 |
Why?
|
| Surveys and Questionnaires | 3 | 2025 | 4003 | 0.130 |
Why?
|
| Qualitative Research | 1 | 2020 | 669 | 0.130 |
Why?
|
| Surgical Wound Infection | 3 | 2023 | 273 | 0.120 |
Why?
|
| Decision Making | 1 | 2020 | 703 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 380 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 391 | 0.110 |
Why?
|
| Quality of Life | 2 | 2021 | 2161 | 0.110 |
Why?
|
| Physicians | 1 | 2020 | 642 | 0.100 |
Why?
|
| Time Factors | 2 | 2020 | 6448 | 0.100 |
Why?
|
| Obesity | 1 | 2024 | 2395 | 0.100 |
Why?
|
| Fibrin | 2 | 2022 | 64 | 0.090 |
Why?
|
| Delphi Technique | 2 | 2022 | 241 | 0.080 |
Why?
|
| Female | 9 | 2024 | 70695 | 0.080 |
Why?
|
| Thrombolytic Therapy | 2 | 2021 | 215 | 0.080 |
Why?
|
| Prospective Studies | 3 | 2025 | 6572 | 0.070 |
Why?
|
| Male | 7 | 2024 | 64967 | 0.070 |
Why?
|
| Anticoagulants | 2 | 2021 | 609 | 0.060 |
Why?
|
| Extracellular Space | 1 | 2022 | 85 | 0.050 |
Why?
|
| Surgical Mesh | 1 | 2023 | 67 | 0.050 |
Why?
|
| Vimentin | 1 | 2022 | 67 | 0.050 |
Why?
|
| Fibrinogen | 1 | 2022 | 157 | 0.050 |
Why?
|
| Sexual Harassment | 1 | 2020 | 20 | 0.040 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2022 | 128 | 0.040 |
Why?
|
| Laparotomy | 1 | 2021 | 144 | 0.040 |
Why?
|
| Coronavirus | 1 | 2020 | 27 | 0.040 |
Why?
|
| Journal Impact Factor | 1 | 2019 | 24 | 0.040 |
Why?
|
| Income | 1 | 2020 | 139 | 0.040 |
Why?
|
| Vasoconstrictor Agents | 1 | 2020 | 141 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 2 | 2022 | 2555 | 0.040 |
Why?
|
| Operative Time | 1 | 2020 | 195 | 0.040 |
Why?
|
| Medicine | 1 | 2020 | 106 | 0.040 |
Why?
|
| Hospital Costs | 1 | 2020 | 187 | 0.040 |
Why?
|
| Research | 1 | 2020 | 265 | 0.040 |
Why?
|
| Perception | 1 | 2020 | 237 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2021 | 1658 | 0.030 |
Why?
|
| Reoperation | 1 | 2020 | 853 | 0.030 |
Why?
|
| Faculty, Medical | 1 | 2020 | 277 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 299 | 0.030 |
Why?
|
| Recurrence | 1 | 2020 | 1469 | 0.030 |
Why?
|
| Time-to-Treatment | 1 | 2018 | 211 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2020 | 523 | 0.030 |
Why?
|
| Inflammation | 1 | 2022 | 1519 | 0.030 |
Why?
|
| Length of Stay | 1 | 2020 | 1380 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3766 | 0.020 |
Why?
|
| Pandemics | 1 | 2020 | 1183 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 1170 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2019 | 17416 | 0.020 |
Why?
|
| Middle Aged | 2 | 2021 | 28998 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2020 | 1247 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 7104 | 0.020 |
Why?
|
| United States | 1 | 2020 | 11667 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 21438 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 31575 | 0.010 |
Why?
|